Richard Laing, MBChB, MSc (CHDC) MD
Professor
Boston University School of Public Health
Dept of Global Health

MD, University of Zimbabwe
MBChB, University of Zimbabwe
MSc, University of London




Originally trained as a medical doctor, worked in the Ministry of Health in Zimbabwe for 18 years at all levels, during which time undertook postgraduate Masters and Doctoral studies in England on Community Health for Developing countries and on Comparative Health Systems & Policy Analysis.

Worked for six years as a Boston based consultant establishing the International Network for the Rational Use of Drugs (INRUD) consulting, teaching and writing.
Moved to Boston University School of Public Health teaching, researching and consulting mostly on Pharmaceutical Policy Issues.

Worked at WHO (2003-2013), Geneva on Pharmaceutical Policy Issues focusing on Pharmaceutical Innovation, Access and Pricing and integration of National Medicine Policies into National Health Policies.

Since 2014 working at Boston University School of Public Health as a Professor of Global Health teaching primarily on the Pharmaceuticals track and as an Extraordinary Professor at University of Western Cape School of Public Health working on developing materials, short course and distance learning courses related to pharmaceutical management.

Undertaking research on Access to Insulin and evaluation of industry initiated activities related to access to medicines for Non Communicable Diseases.

2009 Utrecht University: Honorary degree Doctoris Honoris Causae
1985-1986 Beit Trust: Beit Fellowship
1984-1985 Commonwealth Secretariat: Commonwealth Fellowship


IFPMA SOW 2
04/01/2017 - 03/31/2020 (PI)
International Federation of Pharmaceutical Manufacturers Association


Novartis Access Initiative Task Order 4
11/01/2017 - 10/31/2019 (PI)
Sandoz International GmbH


Evaluation of Novartis Access in Kenya - Scope of Work 5
01/01/2019 - 09/30/2019 (PI)
Sandoz International GmbH


Novartis Access Initiative Task Order 3
10/01/2016 - 04/30/2018 (PI)
Sandoz International GmbH


Novartis Access Initiative Task Order 2
04/29/2016 - 02/28/2018 (PI)
Sandoz International GmbH


IFPMA SOW 1
08/01/2016 - 12/30/2017 (PI)
International Federation of Pharmaceutical Manufacturers Association


Novartis Access Initiative Task Order 1
12/01/2015 - 04/30/2017 (PI)
Sandoz International GmbH





Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Beran D, Laing RO, Kaplan W, Knox R, Sharma A, Wirtz VJ, Frye J, Ewen M. A perspective on global access to insulin: a descriptive study of the market, trade flows and prices. Diabet Med. 2019 Jun; 36(6):726-733.View Related Profiles. PMID: 30888075.
     
  2. Mpanza NM, Bradley H, Laing R. Reasons why insured consumers co-pay for medicines at retail pharmacies in Pretoria, South Africa. Afr J Prim Health Care Fam Med. 2019 Mar 27; 11(1):e1-e6. PMID: 31038333.
     
  3. Rockers PC, Laing RO, Ashigbie PG, Onyango MA, Mukiira CK, Wirtz VJ. Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trial. Lancet Glob Health. 2019 Apr; 7(4):e492-e502.View Related Profiles. PMID: 30799142.
     
  4. Syed N, Rockers PC, Vian T, Onyango M, Laing RO, Wirtz VJ. Access to Antihypertensive Medicines at the Household Level: A Study From 8 Counties of Kenya. Glob Heart. 2018 12; 13(4):247-253.e5.View Related Profiles. PMID: 30245176.
     
  5. Onyango MA, Vian T, Hirsch I, Salvi DD, Laing R, Rockers PC, Ashigbie PG, Wirtz VJ. Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study. PLoS One. 2018; 13(8):e0201917.View Related Profiles. PMID: 30142218.
     
  6. Mehrtash H, Laing R, Wirtz VJ. Comparative analysis of essential medicines for cardiovascular diseases in countries of the WHO Eastern Mediterranean Region. East Mediterr Health J. 2018 Jul 17; 24(5):427-434.View Related Profiles. PMID: 30043961.
     
  7. Rockers PC, Laing RO, Wirtz VJ. Equity in access to non-communicable disease medicines: a cross-sectional study in Kenya. BMJ Glob Health. 2018; 3(3):e000828.View Related Profiles. PMID: 29989082.
     
  8. Wirtz VJ, Turpin K, Laing RO, Mukiira CK, Rockers PC. Access to medicines for asthma, diabetes and hypertension in eight counties of Kenya. Trop Med Int Health. 2018 08; 23(8):879-885.View Related Profiles. PMID: 29808960; DOI: 10.1111/tmi.13081;.
     
  9. Hailu S, Rockers PC, Vian T, Onyango M, Laing R,Wirtz VJ. Access to diabetes medicines at the household level in eight counties of Kenya. J Diabetol. 2018; (9):45-55.
  10. Barakat D, Rockers PC, Vian T, Onyango MA, Laing RO, Wirtz VJ. Access to asthma medicines at the household level in eight counties of Kenya. Int J Tuberc Lung Dis. 2018 05 01; 22(5):585-590.View Related Profiles. PMID: 29663966.
     
Showing 10 of 95 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 93 publications over 29 distinct years, with a maximum of 8 publications in 2016

YearPublications
19801
19811
19822
19831
19863
19871
19882
19892
19906
19915
19934
19951
20002
20011
20021
20034
20042
20072
20092
20106
20114
20123
20136
20144
20155
20168
20174
20187
20193
Contact for Mentoring:


801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


Laing's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department